FGC
INSY

Financial Gravity Companies’s Insys Therapeutics, Inc. INSY Stock Holding History

Financial Gravity Companies’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$0 Buy
+52
New +$361 ﹤0.01% 1586
2018
Q1 		$0 Sell
57
-4,410
-99% -$36.4K ﹤0.01% 1749
2017
Q4 		$42K Buy
+4,467
New +$29.2K 0.05% 338

Other funds holding INSY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Financial Gravity Companies's INSY Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Insys Therapeutics, Inc. (INSY) in Q4 2018: 52 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1586 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in INSY as recently as Q1 2018.

Financial Gravity Companies first reported a position in INSY in Q4 2017 and has held it in 3 quarters since. The position peaked at $42K in Q4 2017. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2018.

  • Financial Gravity Companies held 52 shares of Insys Therapeutics, Inc. worth $0 as of Q4 2018.
  • Insys Therapeutics, Inc. was a new Financial Gravity Companies position in Q4 2018.
  • Insys Therapeutics, Inc. made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1586 holding.
  • Financial Gravity Companies first reported a position in Insys Therapeutics, Inc. in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's Insys Therapeutics, Inc. position peaked at $42K in Q4 2017.
  • 113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.